glp-1 drugs for parkinson's disease Are we measuring the wrong primary outcome for Parkinson's? Spoiler alert: the pooled data suggests we should pivot away from a motor outcome. Should we think cognitive, autonomic, sleep If GLP-1 Drugs Are Good

de Souza, G.A

Cofounder and CEO Marc Washington, who started pitching his wares as Natures Ozempic a few months ago (a claim some legal experts have urged food brands to avoid), is now being inundated with inquiries as retailers such as Sprouts [which has just launched his brand nationwide] seek to capitalize on consumer interest in Supergut, which has historically been positioned as a gut health product

TripleHormone-Receptor Agonist Retatrutide for Obesity a Phase 2 Trial

Read source Hunter, G

At La Jolla Recovery, we integrate the latest neuroscience into our treatment approach because we know that recovery is not one-size-fits-all